tetano
Editor, Senior Moderator
Am J Vet Res
. 2023 Aug 14;1-6.
doi: 10.2460/ajvr.23.05.0117. Online ahead of print. Subcutaneous and intramuscular administration of a SARS-CoV-2 vaccine are similarly effective in generating a humoral response in domestic goats (Capra hircus)
Tess A Rooney[SUP] 1 [/SUP], Shannon Cerveny[SUP] 2 [/SUP], Ronan Eustace[SUP] 3 4 [/SUP], Ryan Colburn[SUP] 5 [/SUP], Rhea S Gerdes[SUP] 6 [/SUP], Diego G Diel[SUP] 6 [/SUP], John Hardham[SUP] 7 [/SUP], Kimberly Thompson[SUP] 1 4 [/SUP]
Affiliations
Objective: To determine severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) serum antibody titers in domestic goats after SC and IM administration of an experimental, veterinary SARS-CoV-2 vaccine.
Animals: 31 healthy adult domestic goats from 4 zoological institutions.
Methods: On day 0, blood was collected for baseline serum titer before vaccination with 1 mL SARS-CoV-2 recombinant S protein vaccine SC (n = 22) or IM (n = 9). A booster vaccination was administered 21 (SC group) or 28 days (IM group) after the initial vaccine and blood samples were collected at days 21 (SC group) or 28 (IM group), 42, 90, and 180 postvaccinations. The study took place between September 27, 2021, and June 01, 2022. Seroconversion for SARS-CoV-2 was assessed by a SARS-CoV-2 virus neutralization (VN) assay.
Results: Before vaccination, no goats had detectable antibodies. On day 42, 100% of goats had detectable serum titers. Serum titers peaked at day 42 for 94% of goats vaccinated by either route of administration. There was a significant difference between SC and IM groups regarding the proportion of goats with detectable titers on day 21/28 (68% vs 0%, respectively) and day 180 (50% vs 89%, respectively), relative to day 0.
Clinical relevance: The 2 vaccination protocols (SC 21 days apart and IM 28 days apart) were similarly effective in mounting serum antibody response in goats. The SC route of administration appeared to have a more rapid onset of immunity, while the IM route may have produced a longer duration of immunity. These data may be useful in determining appropriate SARS-CoV-2 vaccination schedules in ruminants.
Keywords: SARS-CoV-2; goat; humoral immunity; ruminant; vaccination.
. 2023 Aug 14;1-6.
doi: 10.2460/ajvr.23.05.0117. Online ahead of print. Subcutaneous and intramuscular administration of a SARS-CoV-2 vaccine are similarly effective in generating a humoral response in domestic goats (Capra hircus)
Tess A Rooney[SUP] 1 [/SUP], Shannon Cerveny[SUP] 2 [/SUP], Ronan Eustace[SUP] 3 4 [/SUP], Ryan Colburn[SUP] 5 [/SUP], Rhea S Gerdes[SUP] 6 [/SUP], Diego G Diel[SUP] 6 [/SUP], John Hardham[SUP] 7 [/SUP], Kimberly Thompson[SUP] 1 4 [/SUP]
Affiliations
- PMID: 37562776
- DOI: 10.2460/ajvr.23.05.0117
Objective: To determine severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) serum antibody titers in domestic goats after SC and IM administration of an experimental, veterinary SARS-CoV-2 vaccine.
Animals: 31 healthy adult domestic goats from 4 zoological institutions.
Methods: On day 0, blood was collected for baseline serum titer before vaccination with 1 mL SARS-CoV-2 recombinant S protein vaccine SC (n = 22) or IM (n = 9). A booster vaccination was administered 21 (SC group) or 28 days (IM group) after the initial vaccine and blood samples were collected at days 21 (SC group) or 28 (IM group), 42, 90, and 180 postvaccinations. The study took place between September 27, 2021, and June 01, 2022. Seroconversion for SARS-CoV-2 was assessed by a SARS-CoV-2 virus neutralization (VN) assay.
Results: Before vaccination, no goats had detectable antibodies. On day 42, 100% of goats had detectable serum titers. Serum titers peaked at day 42 for 94% of goats vaccinated by either route of administration. There was a significant difference between SC and IM groups regarding the proportion of goats with detectable titers on day 21/28 (68% vs 0%, respectively) and day 180 (50% vs 89%, respectively), relative to day 0.
Clinical relevance: The 2 vaccination protocols (SC 21 days apart and IM 28 days apart) were similarly effective in mounting serum antibody response in goats. The SC route of administration appeared to have a more rapid onset of immunity, while the IM route may have produced a longer duration of immunity. These data may be useful in determining appropriate SARS-CoV-2 vaccination schedules in ruminants.
Keywords: SARS-CoV-2; goat; humoral immunity; ruminant; vaccination.